Pluri Inc. Increase (Decrease) in Restricted Cash
Pluri Inc. (PLUR) reported Increase (Decrease) in Restricted Cash of -$1.08 million for the 9-month period ending 2019-03-31, per its 10-Q filed 2019-05-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2019-05-06
- Pluri Inc. increase (decrease) in restricted cash for the quarter ending 2019-03-31 was $201.00K.
- Pluri Inc. increase (decrease) in restricted cash for the quarter ending 2018-12-31 was -$126.00K, a 506.45% decline year-over-year.
- Pluri Inc. increase (decrease) in restricted cash for the quarter ending 2018-09-30 was -$1.16M.
- Pluri Inc. increase (decrease) in restricted cash for the quarter ending 2018-03-31 was -$119.00K.
- Pluri Inc. increase (decrease) in restricted cash for fiscal 2016 was -$542.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2019-03-31 | $201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $75.00K derived: sum of 2 quarters · filed 2019-05-06 | -$1.08M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | -$1.28M 10-Q · filed 2019-02-06 | ||
| 2018-09-30 | -$1.16M 10-Q · filed 2018-11-07 | |||
| 2018-03-31 | -$119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$88.00K derived: sum of 2 quarters · filed 2018-05-09 | -$1.08M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | -$965.00K 10-Q · filed 2018-02-06 | ||
| 2017-09-30 | -$996.00K 10-Q · filed 2017-11-07 | |||
| 2017-03-31 | -$389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$416.00K derived: sum of 2 quarters · filed 2017-05-08 | -$959.00K 10-Q · filed 2017-05-08 | -$980.00K derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-12-31 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$570.00K 10-Q · filed 2017-02-08 | -$591.00K derived: sum of 3 quarters · filed 2017-02-08 | -$569.00K derived: sum of 4 quarters · filed 2017-02-08 |
| 2016-09-30 | -$543.00K 10-Q · filed 2016-11-07 | -$564.00K derived: sum of 2 quarters · filed 2016-11-07 | -$542.00K derived: sum of 3 quarters · filed 2016-11-07 | |
| 2016-06-30 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $1.00K derived: sum of 2 quarters · filed 2016-09-07 | -$542.00K 10-K · filed 2016-09-07 | |
| 2016-03-31 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$521.00K 10-Q · filed 2016-05-09 | ||
| 2015-12-31 | -$543.00K 10-Q · filed 2016-02-08 | |||
| 2015-03-31 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | -$4.12M derived: sum of 2 quarters · filed 2015-05-06 | -$3.97M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$4.25M 10-Q · filed 2015-02-05 | ||
| 2014-09-30 | $155.00K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |